CNO Financial Group announced a virtual investor briefing on September 1, 2026, focusing on its Worksite Division and Medicare business. The event will include presentations on market opportunities, growth strategies, and business fundamentals, with Q&A sessions featuring senior management. This is the third briefing in a series aimed at deepening investor understanding of CNO's business and long-term prospects. Investors can participate via webcast or replay through the company's website.
Interim results from the Phase 3 DASL-HiCaP trial show that adding darolutamide to standard androgen deprivation therapy (ADT) and radiation therapy reduces the risk of metastasis or death by 58% in prostate cancer patients at high risk of recurrence...
Anthropic reported a massive increase in revenue, reaching $16.3 billion in the first half of 2026 compared to just $1.1 billion in the same period last year. This surge highlights rapid growth and strong demand for its products or services. The dram...
LlamaLend V2 strategy using 20x leverage on syrupUSDC reported a 37.1% yield, while another pool pairing sUSG with reUSD showed a 13.4% yield. The platform isolates lending markets with separate price feeds and borrowing caps, allowing supported Curv...
Solayer Pay has expanded its card app to accept stablecoin deposits directly from five blockchain networks: Solana, Ethereum, Arbitrum, BNB Chain, and Base. This update simplifies the process for users to fund their cards using stablecoins across mul...
Vertex Pharmaceuticals presented updates on its kidney disease research and development programs at the American Society of Nephrology (ASN) Kidney Week 2026. The event featured discussions on their portfolio, including new data on the AMKD program w...
